We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

116 hedge funds and large institutions have $300M invested in Viking Therapeutics in 2018 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 28 increasing their positions, 13 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 17

228% more capital invested

Capital invested by funds: $91.4M → $300M (+$209M)

115% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 13

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

76% more funds holding

Funds holding: 66 → 116 (+50)

28% more call options, than puts

Call options by funds: $9.5M | Put options by funds: $7.4M

12.76% more ownership

Funds ownership: 41.07% → 53.84% (+13%)

Holders
116
Holders Change
+50
Holders Change %
+75.76%
% of All Funds
2.66%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
68
Increased
28
Reduced
13
Closed
17
Calls
$9.5M
Puts
$7.4M
Net Calls
+$2.1M
Net Calls Change
+$1.57M

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$29.7M
2
BlackRock
BlackRock
New York
+$17M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$13.7M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$5.69M
5
ACP
Acuta Capital Partners
California
+$4.99M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$8.87M
2
SCM
Sio Capital Management
New York
-$6.62M
3
SFM
Sphera Funds Management
Israel
-$5.39M
4
Millennium Management
Millennium Management
New York
-$4.38M
5
Victory Capital Management
Victory Capital Management
Texas
-$3.99M
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
26
Barclays
United Kingdom
$2.27M +$1.49M +224,280 +1,529%
Deutsche Bank
27
Deutsche Bank
Germany
$2.05M +$1.43M +215,512 +31,928%
Group One Trading
28
Group One Trading
Illinois
$1.66M +$970K +145,896 +504%
ACM
29
Asymmetry Capital Management
California
$1.46M +$1.03M +154,207 New
Acadian Asset Management
30
Acadian Asset Management
Massachusetts
$1.46M +$1.02M +153,427 New
MIM
31
Monashee Investment Management
Massachusetts
$1.42M – – –
HVC
32
Healthcare Value Capital
New Jersey
$1.42M +$998K +150,000 New
CC
33
Cornerstone Capital
California
$1.38M +$391K +58,850 +68%
Ameriprise
34
Ameriprise
Minnesota
$1.25M +$885K +133,064 New
EGI
35
EAM Global Investors
California
$1.1M -$644K -96,764 -46%
Goldman Sachs
36
Goldman Sachs
New York
$1.09M -$641K -96,333 -46%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$967K +$677K +101,846 New
MCM
38
Moore Capital Management
New York
$949K +$665K +100,000 New
Morgan Stanley
39
Morgan Stanley
New York
$931K +$567K +85,255 +662%
TCIM
40
TIAA CREF Investment Management
New York
$918K +$643K +96,734 New
SEI Investments
41
SEI Investments
Pennsylvania
$878K +$616K +92,565 New
Charles Schwab
42
Charles Schwab
California
$875K +$613K +92,100 New
CS
43
Credit Suisse
Switzerland
$821K +$575K +86,488 New
Russell Investments Group
44
Russell Investments Group
United Kingdom
$810K +$503K +75,635 +782%
WMSA
45
Weiss Multi-Strategy Advisers
New York
$807K +$565K +85,000 New
TA
46
Teachers Advisors
New York
$792K +$555K +83,430 New
JGC
47
J. Goldman & Co
New York
$785K +$550K +82,698 New
UBS Group
48
UBS Group
Switzerland
$780K +$126K +18,872 +30%
PCM
49
Prelude Capital Management
New York
$755K +$529K +79,512 New
AQR Capital Management
50
AQR Capital Management
Connecticut
$754K +$529K +79,476 New
1
2
3 4 5

VKTX Hedge Fund Activity: Q2 2018 in Review

116 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q2 2018, worth a combined $300M — up 228% from $91.4M a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new VKTX positions and 17 closed out — a net gain of 51 holders — while 28 added to existing stakes and 13 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $29.7M. The largest seller was RA Capital Management, exiting entirely with an estimated $8.87M sold.

  • 116 institutional investors held Viking Therapeutics (VKTX) as of Q2 2018, up from 66 in Q1 2018.
  • Funds reported $300M of Viking Therapeutics stock for Q2 2018, up 228% quarter-over-quarter.
  • 68 funds opened new Viking Therapeutics positions in Q2 2018 and 17 closed out, a net change of +51 holders.
  • The largest Viking Therapeutics buyer in Q2 2018 was Avoro Capital Advisors, an estimated $29.7M added.
  • The largest Viking Therapeutics seller in Q2 2018 was RA Capital Management, an estimated $8.87M sold.

Based on aggregated 13F filings for Q2 2018.